Senseonics Holdings(SENS)今日盘中股价大涨超过50%,引发市场广泛关注。公司新推出的Eversense 365连续血糖监测系统,以及第四季度亮眼的业绩数据是导致股价大涨的主要原因。
Eversense 365系统可通过单个植入式传感器监控长达365天的血糖水平,在推出后就引起了强烈热捻。自该系统上市以来,从竞争对手产品转向使用Eversense系统的患者增加了49%。与此同时,SENS公司披露的第四季度业绩数据也超出预期。第四季度直接面向消费者销售线索较上个季度翻了一番,月度新患者出货量达到历史新高的600例。
展望全年,2024年公司患者基数比上年增长56%,约6000名患者。公司还计划在更多地区推广Eversense 365系统。市场对SENS公司长期增长前景预期向好,推动当日股价出现大涨行情。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.